{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2018:GMRUY5IX735T76IO6CSTS7SVFI","short_pith_number":"pith:GMRUY5IX","canonical_record":{"source":{"id":"1808.08375","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/publicdomain/zero/1.0/","primary_cat":"q-bio.BM","submitted_at":"2018-08-25T08:25:21Z","cross_cats_sorted":[],"title_canon_sha256":"2f3598d0ba97d763dae6a2cd3f2eef3005418ff0e8190076ab2dc70923153609","abstract_canon_sha256":"5740ded1e94c68049031840c6715ed0769e1780724cef63fbc7028bc81096c50"},"schema_version":"1.0"},"canonical_sha256":"33234c7517fefb3ff90ef0a5397e552a219e44aeadb734b1e832f51ef1444f43","source":{"kind":"arxiv","id":"1808.08375","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1808.08375","created_at":"2026-05-18T00:07:16Z"},{"alias_kind":"arxiv_version","alias_value":"1808.08375v1","created_at":"2026-05-18T00:07:16Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1808.08375","created_at":"2026-05-18T00:07:16Z"},{"alias_kind":"pith_short_12","alias_value":"GMRUY5IX735T","created_at":"2026-05-18T12:32:25Z"},{"alias_kind":"pith_short_16","alias_value":"GMRUY5IX735T76IO","created_at":"2026-05-18T12:32:25Z"},{"alias_kind":"pith_short_8","alias_value":"GMRUY5IX","created_at":"2026-05-18T12:32:25Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2018:GMRUY5IX735T76IO6CSTS7SVFI","target":"record","payload":{"canonical_record":{"source":{"id":"1808.08375","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/publicdomain/zero/1.0/","primary_cat":"q-bio.BM","submitted_at":"2018-08-25T08:25:21Z","cross_cats_sorted":[],"title_canon_sha256":"2f3598d0ba97d763dae6a2cd3f2eef3005418ff0e8190076ab2dc70923153609","abstract_canon_sha256":"5740ded1e94c68049031840c6715ed0769e1780724cef63fbc7028bc81096c50"},"schema_version":"1.0"},"canonical_sha256":"33234c7517fefb3ff90ef0a5397e552a219e44aeadb734b1e832f51ef1444f43","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:07:16.738490Z","signature_b64":"cDrV8inBWrv7Mc6tXb1xxbEc0RLg3Sme3YBMfrOOZmrUjg0ZKFLDN+wngC5ot0DscMZMMzvCPjOW8LjE/JiQAg==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"33234c7517fefb3ff90ef0a5397e552a219e44aeadb734b1e832f51ef1444f43","last_reissued_at":"2026-05-18T00:07:16.737875Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:07:16.737875Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1808.08375","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:07:16Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"/yHhKUFuzaWa+iNOrinETPwF3uLK/fJm84/cm2JLwkm0091lx7os/fblfris0tNIkwd03ubdI9kGBbPFYPGEDg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-07-15T22:45:57.892957Z"},"content_sha256":"95fb0d87e7cca49e9231da241d16a30c8904bc0acd88cc1c5c7d6b6e91f2bac6","schema_version":"1.0","event_id":"sha256:95fb0d87e7cca49e9231da241d16a30c8904bc0acd88cc1c5c7d6b6e91f2bac6"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2018:GMRUY5IX735T76IO6CSTS7SVFI","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Molecular dynamics simulations reveal the role of ceramicine B as novel PPAR{\\gamma} partial agonist against type 2 diabetes","license":"http://creativecommons.org/publicdomain/zero/1.0/","headline":"","cross_cats":[],"primary_cat":"q-bio.BM","authors_text":"Bidyut Mallick","submitted_at":"2018-08-25T08:25:21Z","abstract_excerpt":"Peroxisome proliferator-activated receptors gamma (PPAR{\\gamma}) are ligand-activated controllers of various metabolic actions and insulin sensitivity. PPAR{\\gamma} is thus considered as an important target to treat type 2 diabetes. Available PPAR{\\gamma} drugs (full agonists) have robust insulin-sensitizing properties but are accompanied by severe side effects leading to complicated health problems. Here, we have used molecular docking and a molecular dynamics simulation study to find a novel PPAR{\\gamma} ligand from a natural product. Our study suggests that the inhibition of ceramicine B in"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1808.08375","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:07:16Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"IM2btmQH403NgjjNXRvHtnMRnu8zFtt6yunB4FUkvuUVce5udMyyFDvp9hEbUeZSJM2ETfv6XWVQ7u1FelD/BA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-07-15T22:45:57.893323Z"},"content_sha256":"2928b17f79d572037fdd3f6de2eb7a51e3d77b4df387bf03615ef176b7062f9f","schema_version":"1.0","event_id":"sha256:2928b17f79d572037fdd3f6de2eb7a51e3d77b4df387bf03615ef176b7062f9f"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/GMRUY5IX735T76IO6CSTS7SVFI/bundle.json","state_url":"https://pith.science/pith/GMRUY5IX735T76IO6CSTS7SVFI/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/GMRUY5IX735T76IO6CSTS7SVFI/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-07-15T22:45:57Z","links":{"resolver":"https://pith.science/pith/GMRUY5IX735T76IO6CSTS7SVFI","bundle":"https://pith.science/pith/GMRUY5IX735T76IO6CSTS7SVFI/bundle.json","state":"https://pith.science/pith/GMRUY5IX735T76IO6CSTS7SVFI/state.json","well_known_bundle":"https://pith.science/.well-known/pith/GMRUY5IX735T76IO6CSTS7SVFI/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2018:GMRUY5IX735T76IO6CSTS7SVFI","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"5740ded1e94c68049031840c6715ed0769e1780724cef63fbc7028bc81096c50","cross_cats_sorted":[],"license":"http://creativecommons.org/publicdomain/zero/1.0/","primary_cat":"q-bio.BM","submitted_at":"2018-08-25T08:25:21Z","title_canon_sha256":"2f3598d0ba97d763dae6a2cd3f2eef3005418ff0e8190076ab2dc70923153609"},"schema_version":"1.0","source":{"id":"1808.08375","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1808.08375","created_at":"2026-05-18T00:07:16Z"},{"alias_kind":"arxiv_version","alias_value":"1808.08375v1","created_at":"2026-05-18T00:07:16Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1808.08375","created_at":"2026-05-18T00:07:16Z"},{"alias_kind":"pith_short_12","alias_value":"GMRUY5IX735T","created_at":"2026-05-18T12:32:25Z"},{"alias_kind":"pith_short_16","alias_value":"GMRUY5IX735T76IO","created_at":"2026-05-18T12:32:25Z"},{"alias_kind":"pith_short_8","alias_value":"GMRUY5IX","created_at":"2026-05-18T12:32:25Z"}],"graph_snapshots":[{"event_id":"sha256:2928b17f79d572037fdd3f6de2eb7a51e3d77b4df387bf03615ef176b7062f9f","target":"graph","created_at":"2026-05-18T00:07:16Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Peroxisome proliferator-activated receptors gamma (PPAR{\\gamma}) are ligand-activated controllers of various metabolic actions and insulin sensitivity. PPAR{\\gamma} is thus considered as an important target to treat type 2 diabetes. Available PPAR{\\gamma} drugs (full agonists) have robust insulin-sensitizing properties but are accompanied by severe side effects leading to complicated health problems. Here, we have used molecular docking and a molecular dynamics simulation study to find a novel PPAR{\\gamma} ligand from a natural product. Our study suggests that the inhibition of ceramicine B in","authors_text":"Bidyut Mallick","cross_cats":[],"headline":"","license":"http://creativecommons.org/publicdomain/zero/1.0/","primary_cat":"q-bio.BM","submitted_at":"2018-08-25T08:25:21Z","title":"Molecular dynamics simulations reveal the role of ceramicine B as novel PPAR{\\gamma} partial agonist against type 2 diabetes"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1808.08375","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:95fb0d87e7cca49e9231da241d16a30c8904bc0acd88cc1c5c7d6b6e91f2bac6","target":"record","created_at":"2026-05-18T00:07:16Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"5740ded1e94c68049031840c6715ed0769e1780724cef63fbc7028bc81096c50","cross_cats_sorted":[],"license":"http://creativecommons.org/publicdomain/zero/1.0/","primary_cat":"q-bio.BM","submitted_at":"2018-08-25T08:25:21Z","title_canon_sha256":"2f3598d0ba97d763dae6a2cd3f2eef3005418ff0e8190076ab2dc70923153609"},"schema_version":"1.0","source":{"id":"1808.08375","kind":"arxiv","version":1}},"canonical_sha256":"33234c7517fefb3ff90ef0a5397e552a219e44aeadb734b1e832f51ef1444f43","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"33234c7517fefb3ff90ef0a5397e552a219e44aeadb734b1e832f51ef1444f43","first_computed_at":"2026-05-18T00:07:16.737875Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:07:16.737875Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"cDrV8inBWrv7Mc6tXb1xxbEc0RLg3Sme3YBMfrOOZmrUjg0ZKFLDN+wngC5ot0DscMZMMzvCPjOW8LjE/JiQAg==","signature_status":"signed_v1","signed_at":"2026-05-18T00:07:16.738490Z","signed_message":"canonical_sha256_bytes"},"source_id":"1808.08375","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:95fb0d87e7cca49e9231da241d16a30c8904bc0acd88cc1c5c7d6b6e91f2bac6","sha256:2928b17f79d572037fdd3f6de2eb7a51e3d77b4df387bf03615ef176b7062f9f"],"state_sha256":"bb7f7a01f4ca31ecc89e9ee0fe0d21a54e899ca487768e9dd5c1e508f0e0a68e"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"YaMoqIrT+ahZWibXQfcAdql+Al48z5i0cz/agojWCGzgFuzfgWEwkSnHDWs+L4JmuiPLgrRsAN7ncF5ij28fCg==","signed_message":"bundle_sha256_bytes","signed_at":"2026-07-15T22:45:57.895498Z","bundle_sha256":"2485820149d889e006b501243d6fa50d021e4485b49c832bcdf80a3fa94f8a51"}}